CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
暂无分享,去创建一个
K. Odunsi | P. Shrikant | S. Battaglia | R. Koya | T. Chodon | B. Lichty | J. Matsuzaki | A. McGray | C. Eppolito | A. Miliotto | R. Muthuswamy | Wenjun He | Tsuji Takemasa | Ravikumar Muthuswamy | Junko Matsuzaki
[1] A. Vincent-Salomon,et al. Transcriptional and Functional Analysis of CD1c+ Human Dendritic Cells Identifies a CD163+ Subset Priming CD8+CD103+ T Cells , 2020, Immunity.
[2] Kouji Matsushima,et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways , 2019, The Journal of experimental medicine.
[3] S. Jameson,et al. The Functional Requirement for CD69 in Establishment of Resident Memory CD8+ T Cells Varies with Tissue Location , 2019, The Journal of Immunology.
[4] M. Seshadri,et al. Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer , 2019, Journal of Immunotherapy for Cancer.
[5] E. King,et al. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer , 2019, The Journal of experimental medicine.
[6] D. Masopust,et al. Tissue-Resident T Cells and Other Resident Leukocytes. , 2019, Annual review of immunology.
[7] Scott N. Mueller,et al. Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin , 2018, Nature.
[8] T. Schumacher,et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers , 2018, Nature Medicine.
[9] E. Tartour,et al. Targeting Resident Memory T Cells for Cancer Immunotherapy , 2018, Front. Immunol..
[10] B. Fox,et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors , 2018, Nature Communications.
[11] R. V. van Lier,et al. Tissue-resident memory T cells at the center of immunity to solid tumors , 2018, Nature Immunology.
[12] M. Fehlings,et al. Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.
[13] A. Goldrath,et al. Transcriptional programming of tissue-resident memory CD8+ T cells. , 2018, Current opinion in immunology.
[14] N. Maugeri,et al. The Neutrophil’s Choice: Phagocytose vs Make Neutrophil Extracellular Traps , 2018, Front. Immunol..
[15] Scott N. Mueller,et al. Local proliferation maintains a stable pool of tissue-resident memory T cells after antiviral recall responses , 2018, Nature Immunology.
[16] Wei Wang,et al. Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumors , 2017, Nature.
[17] Scott N. Mueller,et al. Chemokine Receptor–Dependent Control of Skin Tissue–Resident Memory T Cell Formation , 2017, The Journal of Immunology.
[18] I. Melero,et al. Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells , 2017, Nature Communications.
[19] E. King,et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer , 2017, Nature Immunology.
[20] Peisheng Zhang,et al. Resident memory T cells in the skin mediate durable immunity to melanoma , 2017, Science Immunology.
[21] P. Fink,et al. Local Inflammatory Cues Regulate Differentiation and Persistence of CD8+ Tissue-Resident Memory T Cells. , 2017, Cell reports.
[22] X. Deupí,et al. The DRF motif of CXCR6 as chemokine receptor adaptation to adhesion , 2017, PloS one.
[23] P. Puigserver,et al. Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism , 2017, Nature.
[24] Chiara Bonini,et al. T memory stem cells in health and disease , 2017, Nature Medicine.
[25] K. Odunsi,et al. Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer , 2016, Oncoimmunology.
[26] N. McGovern,et al. A High-Dimensional Atlas of Human T Cell Diversity Reveals Tissue-Specific Trafficking and Cytokine Signatures. , 2016, Immunity.
[27] W. Shi,et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes , 2016, Science.
[28] Scott N. Mueller,et al. Tissue-resident memory T cells: local specialists in immune defence , 2015, Nature Reviews Immunology.
[29] D. Pellicci,et al. T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate. , 2015, Immunity.
[30] Fadi G Lakkis,et al. Memory T Cell Migration , 2015, Front. Immunol..
[31] K. Odunsi,et al. LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model , 2015, Oncotarget.
[32] K. Odunsi,et al. Non-redundant Requirement for CXCR3 Signaling during Tumoricidal T Cell Trafficking across Tumor Vascular Checkpoints , 2015, Nature Communications.
[33] B. Nelson,et al. PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer , 2015, Cancer Immunology Research.
[34] J. Schenkel,et al. Tissue-resident memory T cells. , 2014, Immunity.
[35] Andrea J. Radtke,et al. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8⁺ T cells specific for infectious pathogens. , 2014, The Journal of infectious diseases.
[36] Ji-Ying Song,et al. Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert , 2014, Science.
[37] J. Schenkel,et al. Resident memory CD8 T cells trigger protective innate and adaptive immune responses , 2014, Science.
[38] Liang Zhang,et al. Maraba virus as a potent oncolytic vaccine vector. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] Scott N. Mueller,et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin , 2013, Nature Immunology.
[40] M. Bevan,et al. Transforming growth factor-β signaling controls the formation and maintenance of gut-resident memory T cells by regulating migration and retention. , 2013, Immunity.
[41] Thomas Gebhardt,et al. Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.
[42] B. Nelson,et al. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer. , 2010, Gynecologic oncology.
[43] H. Atkins,et al. Identification of genetically modified Maraba virus as an oncolytic rhabdovirus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[44] Thomas Gebhardt,et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus , 2009, Nature Immunology.
[45] Gerd Ritter,et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Rose-John,et al. The Transmembrane CXC-Chemokine Ligand 16 Is Induced by IFN-γ and TNF-α and Shed by the Activity of the Disintegrin-Like Metalloproteinase ADAM10 1 , 2004, The Journal of Immunology.
[47] R. Rabin,et al. CXCR3 Is Induced Early on the Pathway of CD4+ T Cell Differentiation and Bridges Central and Peripheral Functions 12 , 2003, The Journal of Immunology.
[48] George Coukos,et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.
[49] Sharon Engel,et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo , 2000, Nature Immunology.
[50] J L Pace,et al. Development of a syngeneic mouse model for events related to ovarian cancer. , 2000, Carcinogenesis.
[51] A. Luster,et al. Chemokines: Critical Regulators of Memory T Cell Development, Maintenance, and Function. , 2018, Advances in immunology.
[52] Andrea J. Radtke,et al. The Chemokine Receptor CXCR 6 Is Required for the Maintenance of Liver Memory CD 8 + T Cells Speci fi c for Infectious Pathogens , 2014 .